Breaking News Instant updates and real-time market news.

DMPI

DelMar Pharmaceuticals

$0.85

-0.0548 (-6.09%)

16:49
09/28/17
09/28
16:49
09/28/17
16:49

Intracoastal Capital reports 4.99% passive stake in DelMar Pharmaceuticals

DMPI DelMar Pharmaceuticals
$0.85

-0.0548 (-6.09%)

11/16/16
MAXM
11/16/16
NO CHANGE
Target $11
MAXM
Buy
DelMar Pharmaceuticals price target lowered to $11 from $15 at Maxim
Maxim analyst Jason McCarthy lowered his price target on DelMar Pharmaceuticals to $11 from $15, citing extended timelines for the company's Phase 3 program in patients with progressive glioblastoma multiforme who have failed Avastin therapy, which has been pushed out "a bit into 2017." This pushes out a potential commercial launch to 2021, from 2020, estimates McCarthy, who keeps a Buy rating on DelMar shares.
01/05/17
AGIS
01/05/17
INITIATION
Target $16
AGIS
Buy
DelMar Pharmaceuticals initiated with a Buy at Aegis
Aegis analyst Robert LeBoyer initiated DelMar Pharmaceuticals with a Buy and a $16 price target.
08/14/17
MAXM
08/14/17
DOWNGRADE
MAXM
Hold
DelMar Pharmaceuticals downgraded to Hold from Buy at Maxim
08/14/17
MAXM
08/14/17
DOWNGRADE
MAXM
Hold
DelMar downgraded to Hold on capital concerns at Maxim
Maxim analyst Jason McCarthy downgraded DelMar Pharmaceuticals to Hold from Buy saying he sees "significant overhangs" in micro-caps like DelMar to raise the required capital to complete clinical studies. DelMar didn't raise enough capital in its last deal, leaving the company "between a rock and a hard place," the analyst tells investors in an intraday research note. He removed his previous price target of $11.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.